158 related articles for article (PubMed ID: 7968260)
21. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines.
Fujita J; Ohtsuki Y; Bandoh S; Ueda Y; Kubo A; Tojo Y; Yamaji Y; Ishida T
Lung Cancer; 2003 Jan; 39(1):31-6. PubMed ID: 12499091
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.
Stumpf C; Kaemmerer D; Neubauer E; Sänger J; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1921-1932. PubMed ID: 30076481
[TBL] [Abstract][Full Text] [Related]
24. Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms.
Specht E; Kaemmerer D; Sänger J; Wirtz RM; Schulz S; Lupp A
Histopathology; 2015 Sep; 67(3):368-77. PubMed ID: 25641082
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor subtype gene expression in human and rodent tumors.
Eden PA; Taylor JE
Life Sci; 1993; 53(1):85-90. PubMed ID: 8515684
[TBL] [Abstract][Full Text] [Related]
27. Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.
Seki Y; Yoshida Y; Ishimine H; Shinozaki-Ushiku A; Ito Y; Sumitomo K; Nakajima J; Fukayama M; Michiue T; Asashima M; Kurisaki A
Biochem Biophys Res Commun; 2014 Jan; 443(4):1141-7. PubMed ID: 24380866
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced up-regulation of somatostatin receptor expression in small cell lung cancer in vitro.
Oddstig J; Bernhardt P; Nilsson O; Ahlman H; Forssell-Aronsson E
Nucl Med Biol; 2006 Oct; 33(7):841-6. PubMed ID: 17045163
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer.
Lehman JM; Hoeksema MD; Staub J; Qian J; Harris B; Callison JC; Miao J; Shi C; Eisenberg R; Chen H; Chen SC; Massion PP
Int J Cancer; 2019 Mar; 144(5):1104-1114. PubMed ID: 30152518
[TBL] [Abstract][Full Text] [Related]
30. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma.
Graff L; Castrop F; Bauer M; Höfler H; Gratzl M
Cancer Res; 2001 Mar; 61(5):2138-44. PubMed ID: 11280778
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin and its receptor family.
Patel YC
Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor subtype expression in human thyroid tumours.
Klagge A; Krause K; Schierle K; Steinert F; Dralle H; Fuhrer D
Horm Metab Res; 2010 Apr; 42(4):237-40. PubMed ID: 20094970
[TBL] [Abstract][Full Text] [Related]
33. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
34. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
Jaquet P; Saveanu A; Gunz G; Fina F; Zamora AJ; Grino M; Culler MD; Moreau JP; Enjalbert A; Ouafik LH
J Clin Endocrinol Metab; 2000 Feb; 85(2):781-92. PubMed ID: 10690891
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3.
Talme T; Ivanoff J; Hägglund M; Van Neerven RJ; Ivanoff A; Sundqvist KG
Clin Exp Immunol; 2001 Jul; 125(1):71-9. PubMed ID: 11472428
[TBL] [Abstract][Full Text] [Related]
36. Expression of the aromatic L-amino acid decarboxylase mRNA in human tumour cell lines of neuroendocrine and neuroectodermal origin.
Vachtenheim J; Novotná H
Eur J Cancer; 1997 Dec; 33(14):2411-7. PubMed ID: 9616291
[TBL] [Abstract][Full Text] [Related]
37. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
Jaquet P; Gunz G; Saveanu A; Barlier A; Dufour H; Taylor J; Dong J; Kim S; Moreau JP; Culler MD
J Endocrinol Invest; 2005; 28(11 Suppl International):21-7. PubMed ID: 16625841
[TBL] [Abstract][Full Text] [Related]
38. A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients.
Janson ET; Gobl A; Kälkner KM; Oberg K
Cancer Res; 1996 Jun; 56(11):2561-5. PubMed ID: 8653698
[TBL] [Abstract][Full Text] [Related]
39. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.
Plummer HK; Dhar MS; Cekanova M; Schuller HM
BMC Cancer; 2005 Aug; 5():104. PubMed ID: 16109170
[TBL] [Abstract][Full Text] [Related]
40. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
